Ernexa Therapeutics Inc.ERNANASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank56
5Y CAGR-26.0%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-26.0%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 22.40% |
| 2023 | 2.71% |
| 2022 | 10.69% |
| 2021 | -189.94% |
| 2020 | -395.23% |
| 2019 | 101.03% |
| 2018 | 148.63% |
| 2017 | 2286.96% |
| 2016 | 100.55% |
| 2015 | 0.00% |